* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
IJGC Podcast
The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer. Join Editor-in-Chief Dr. Pedro Ramirez and his guests for an interactive and educational experience. Subscribe now or listen on your favourite podcast platform. IJGC - ijgc.bmj.com - is the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.
Episodes
Monday Dec 14, 2020
Monday Dec 14, 2020
In this episode of the IJGC Podcast, Florencia Noll discusses the contents of the December issue of IJGC in Spanish.
Thursday Dec 10, 2020
Thursday Dec 10, 2020
In this issue of the IJGC Podcast, Editorial Fellows Sadie Jones and Navya Nair discuss the contents of the December issue of IJGC.
Wednesday Dec 02, 2020
Wednesday Dec 02, 2020
In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Oliver Zivanovic to discuss updates on role of HIPEC in ovarian cancer. Dr. Zivanovic is a Gynecologic Cancer Surgeon at Memorial Sloan Kettering Cancer Center, with the goal to advance the early detection and treatment of women with gynecologic cancers. His special interests include the treatment of patients with advanced stage ovarian cancer and electronic patient-reported symptom monitoring after cancer surgery.
Wednesday Dec 02, 2020
Wednesday Dec 02, 2020
In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Andrea Mariani to discuss lymphadenectomy vs. SLN: Mayo and Memorial Sloan Kettering experience. Dr. Andrea Mariani is a Full Professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, at Mayo Clinic in Rochester, Minnesota. His research interest is endometrial cancer with a special interest in robotic surgery. He is internationally recognized for his contributions in the advancement of surgical and postoperative treatment of endometrial cancer.
Wednesday Dec 02, 2020
Wednesday Dec 02, 2020
In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Dimitrios Nasioudis a to discuss adjuvant treatment in UPSC limited to endometrium and his article, "Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium," (ijgc.bmj.com/content/early/2020…4/ijgc-2020-001379) the Lead Article in the August 2020 issue of IJGC. Dr. Nasioudis is a resident at the Hospital of the University of Pennsylvania, Philadelphia. His current interests include population science and outcomes research with an emphasis on rare gynecologic tumors.
Monday Nov 30, 2020
Monday Nov 30, 2020
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Simone Marnitz-Schulze and Dr. Christhardt Köhler to discuss the outcomes of UTERUS-11 Trial. Drs. Marnitz-Schulze and Köhler are authors of “Surgical versus Clinical Staging prior to primary Chemoradiation in Patients with Cervical Cancer FIGO Stages IIB-IVA: Oncologic Results of a Prospective Randomized International Multicentre (Uterus-11) Intergroup Study,” which is the Lead Article of the December 2020 issue of the International Journal of Gynecological Cancer.
Highlights:
-Surgical staging prior to chemoradiation in locally advanced cervical cancer is safe, feasible, does not delay chemoradiation
-Lead to an upstaging in 33% of the patients
-Resulted into a statistically significant improvement of DFS in FIGO stage IIB patients
-Resulted into a trend for improved OS and DFS for all subgroups
-Because of high rates of distant metastases, systemic treatment has to be intensified
Tuesday Nov 24, 2020
Tuesday Nov 24, 2020
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Trinidad Labanca to discuss transgender patients and cancer-related screening. Dr. Labanca is a Gynecologist at Hospital Italiano de Buenos Aires and Sexologist at the University of Buenos Aires. She has an MBA with specialization in Healthcare Management from the European Business School and specialized in Transgender Health and Sexual Confirming Genital Surgery at the Institute of Plastic Surgery Dr. Ivan Mañero, in Barcelona, Spain. She has been a WPATH member since 2015. Dr. Labanca currently works in the Department of Gender Diversity and Transgender Health at Hospital Dr. Bernardo Houssay, in Buenos Aires, Argentina.
Podcast Highlights:
1. Gynecologists and gynecologists oncologists should be involved in transgender care, understand gender diversity and promote sexual health
2. Gynecologic cancer screenings should be organ- rather than gender-based.
3. Hormone therapy and surgical status may change screening strategies.
4. There is a need of further high-quality research in the field of Transgender Health.
Friday Nov 13, 2020
Friday Nov 13, 2020
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Javier Magrina to discuss robotic vs open radical hysterectomy in pathology interrogation. Dr. Magrina is a Professor of Obstetrics and Gynecology at Mayo Graduate School of Medicine, and the recipient of the Barbara Woodward Lips Professorship. He is a staff consultant at Mayo Clinic Arizona.
Conclusions:
. robotic radical hysterectomy results in inferior survival as compared to laparotomy.
. robotic radical hysterectomy for early cervical cancer . intraperitoneal recurrences are not seen with laparotomy and appear due to the exfoliation and seeding of cervical cancer cells.
Tuesday Nov 10, 2020
Tuesday Nov 10, 2020
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Julia Pugh and Chloe Logue to discuss psychosexual morbidity in women with ovarian cancer. Dr. Julia Pugh is a Gynaecology Clinical Nurse Specialist and psychosexual therapist based at The Christie Hospital in Manchester, UK. Dr. Pugh completed her Advanced Nursing Practice Masters at the University of Manchester and offers support for psychosexual concerns of men and women with cancer. Dr. Chloe Logue is a practicing junior doctor in Manchester. She completed her academic foundation at the Christie Cancer Hospital in Gynaecological Oncology, supervised by Prof Gordon Jayson.
Highlights:
- 75% of women with ovarian cancer experience psychosexual morbidity, exceeding published general population values.
- Key potential risk factors are: younger age, premenopausal status at diagnosis, extensive surgery, more courses of chemotherapy, cardiovascular co-morbidities and anxiety and depression.
- Common presenting symptoms include: vaginal dryness (81-87%) and pain (77%), amongst reduced sexual desire and activity, impaired orgasm, diminished perceived body image and reduced partner intimacy.
- The review identified that psychosexual issues are not routinely discussed nor adequately managed by clinicians. Psychosexual problems remain a priority for many women with ovarian cancer, many symptoms could be addressed by discussing their concerns and simple physical measures.
Tuesday Nov 03, 2020
Tuesday Nov 03, 2020
In this episode of the IJGC Podcast, Florencia Noll discusses the contents of the November issue of IJGC in Spanish.